CompanyGraph
Shenzhen Kangtai Biological Products Co., Ltd.
300601 · SZSE · China
biokangtai.comFinancials as of FY2025
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleMarket cap is $2B, above the global median of $1.15B
- FinancialsAltman Z-Score 2.57: grey zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.29%Below 5Y avg (0.78%)
Annual Rate
CNY 0.04Paid annual
Payout Ratio
128.6%High
Last Ex-Dividend
Jun 11, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
13.47BCNY2.00B · vs all stocks (USD)
Trailing P/E
173.14xRevenue (TTM)
2.66BCNY394.91M · vs all stocks (USD)
Profit Margin
3.06%Beta
0.6180xvs all stocks
52-Week Change
-35.02%vs all stocks
Market Capitalization
13.47BCNY2.00B · vs all stocks (USD)
Enterprise Value
13.87BCNY2.06B · vs all stocks (USD)
Trailing P/E
173.14xForward P/E
33.67xPrice to Sales (TTM)
5.09xPrice to Book (MRQ)
1.40xEnterprise to Revenue
5.22xEnterprise to EBITDA
31.60xGross Margin
71.10%Profit Margin
3.06%Operating Margin
6.73%Return on Assets (TTM)
0.12%Return on Equity (TTM)
0.84%Revenue (TTM)
2.66BCNY394.91M · vs all stocks (USD)
Revenue per Share (TTM)
2.27CNYUpdated Aug 19, 2026Quarterly Revenue Growth
-2.20%Gross Profit (TTM)
1.84BCNY273.26M · vs all stocks (USD)
EBITDA (TTM)
332.75MCNY49.42M · vs all stocks (USD)
Net Income (TTM)
81.24MCNY12.07M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
48.60%Operating Cash Flow (TTM)
582.60MCNY86.53M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
1.88BCNY279.76M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.0350CNYUpdated Aug 19, 2026Trailing Annual Dividend Yield
0.29%vs all stocks
5-Year Average Dividend Yield
0.78%vs all stocks
Payout Ratio
128.57%Minority Interest (Equity)
-155.09KCNYFY2025 · Dec 31, 2025Revenue
2.67BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
676.61MCNYFY2025 · Dec 31, 2025Gross Profit
2.00BCNYFY2025 · Dec 31, 2025Operating Income
251.37MCNY37.33M · vs all stocks (USD)
Pre-tax Income
45.46MCNYFY2025 · Dec 31, 2025Income Tax Expense
-24.81MCNYFY2025 · Dec 31, 2025Net Income
70.27MCNYFY2025 · Dec 31, 2025EBIT
164.50MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
736.72MCNYFY2025 · Dec 31, 2025Research & Development
543.42MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
931.81MCNYFY2025 · Dec 31, 2025Other Operating Expenses
39.89MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
77.97MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
119.03MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.0600CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.0600CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
1.17BSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
1.17BSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
70.27MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
56.52KCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
332.54MCNYFY2025 · Dec 31, 2025Free Cash Flow
923.53KCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
221.86MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
70.27MCNYFY2025 · Dec 31, 2025Other Non-cash Items
78.71MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
159.19MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
24.37MCNYFY2025 · Dec 31, 2025Capital Expenditures
-331.62MCNYFY2025 · Dec 31, 2025Purchase of Investments
-4.55BCNYFY2025 · Dec 31, 2025Sale of Investments
4.40BCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-484.01MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
39.90MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-262.99MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-131.55MCNYFY2025 · Dec 31, 2025Other Financing Charges
9.84MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-344.81MCNYFY2025 · Dec 31, 2025Shares Outstanding
1.12BSharesUpdated Aug 19, 2026Float Shares
612.32MSharesUpdated Aug 19, 2026% Held by Insiders
47.80%vs all stocks
% Held by Institutions
8.15%vs all stocks
Total Cash (MRQ)
1.88BCNY279.33M · vs all stocks (USD)
Total Cash per Share (MRQ)
1.68CNYUpdated Aug 19, 2026Total Debt (MRQ)
1.93BCNY286.18M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.1994xCurrent Ratio (MRQ)
2.87xBook Value per Share (MRQ)
8.65CNYUpdated Aug 19, 2026Total Assets
14.10BCNY2.09B · vs all stocks (USD)
Total Current Assets
5.99BCNYFY2025 · Dec 31, 2025Total Liabilities
4.46BCNYFY2025 · Dec 31, 2025Total Non-current Assets
8.10BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
2.25BCNYFY2025 · Dec 31, 2025Total Current Liabilities
2.22BCNYFY2025 · Dec 31, 2025Cash
221.90MCNYFY2025 · Dec 31, 2025Cash Equivalents
35.40MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
257.30MCNYFY2025 · Dec 31, 2025Other Short-term Investments
1.69BCNYFY2025 · Dec 31, 2025Accounts Receivable
2.58BCNYFY2025 · Dec 31, 2025Inventory
681.09MCNYFY2025 · Dec 31, 2025Accounts Payable
708.25MCNYFY2025 · Dec 31, 2025Short-term Debt
16.66MCNYFY2025 · Dec 31, 2025Other Current Liabilities
9.58MCNYFY2025 · Dec 31, 2025Long-term Debt
1.87BCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
115.42MCNYFY2025 · Dec 31, 2025Common Stock (Book)
1.12BCNYFY2025 · Dec 31, 2025Retained Earnings
2.13BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
9.63BCNY1.43B · vs all stocks (USD)
52-Week Low
10.70CNYUpdated Aug 19, 202652-Week High
21.12CNYUpdated Aug 19, 202652-Week Change
-35.02%vs all stocks
Beta
0.6180xvs all stocks
50-Day MA
12.04CNYUpdated Aug 19, 2026200-Day MA
14.12CNYUpdated Aug 19, 2026Avg 10-Day Volume
16.54MSharesUpdated Aug 19, 2026Avg 30-Day Volume
16.80MSharesUpdated Aug 19, 2026Diluted EPS (TTM)
0.0700CNYUpdated Aug 19, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow is this stock valued?
Close Below 40W SMA With Profitability
The price sits below its 40-week average, on three profitable years and cash above profit.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.71Profit Margin: 0.03
Financial Health
Altman Z-Score 2.57: grey zoneSignificant
Altman Z-Score: 2.57
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Market cap is $2B, above the global median of $1.15BNotable
Market cap (USD): 2,000,590,988.05Global Median: 1,146,734,693.424
Levered free cash flow is $279.76M, above the global median of $16.24MNotable
Levered free cash flow (USD): 279,760,674.668Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Tibet Rhodiola Pharmaceutical Holding Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Shanghai Innostar Bio-tech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineSenseMakingRule
Viridian Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Nuvation Bio Inc.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Wuhan Healthgen Biotechnology Corp.
Tier 1ProductionApproval-Gated PipelineRule
Syndax Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRule
Sk Bioscience Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
GH Research plc
Tier 1ProductionApproval-Gated PipelineRule
Caplin Point Laboratories Ltd.
Tier 1ProductionApproval-Gated PipelineFlowRule
Ocular Therapeutix Inc.
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Anbio Biotechnology Limited
1 interpretationClose Below 40W SMA With Profitability
Shanghai Mechanical and Electrical Industry Co., Ltd.
1 interpretationClose Below 40W SMA With Profitability
Jiajiayue Group Co., Ltd.
1 interpretationClose Below 40W SMA With Profitability